Nonalcoholic fatty liver disease and liver transplantation
Liver Transplantation2006Vol. 12(4), pp. 523–534
Citations Over TimeTop 10% of 2006 papers
Abstract
Nonalcoholic fatty liver disease affects a substantial proportion of the general population worldwide. This high prevalence of nonalcoholic fatty liver disease has important consequences in the donor selection process for liver transplantation, and in the posttransplant period given the high recurrence rate of disease. This paper reviews the prevalence of nonalcoholic fatty liver disease, its progressive potential, and the implications of this liver condition in both the pre- and post-liver transplantation setting.
Related Papers
- → Nonalcoholic fatty liver disease and liver transplantation(2006)140 cited
- → Is severe progressive liver disease caused by alpha‐1‐antitrypsin deficiency more common in children or adults?(2016)45 cited
- → Liver disease and anesthesia(1993)1 cited
- → Fatty Liver Disease Prediction Using Supervised Learning(2021)1 cited
- → Advances in the application of model for end-stage liver disease and MELD-Na scores in liver transplantation(2019)